501 related articles for article (PubMed ID: 18585527)
21. In vitro replicative properties of replicons constructed using sequence variants of the hepatitis C virus strain AD78 that caused a single-source outbreak of hepatitis C.
Oniangue-Ndza C; Aus dem Siepen M; Lohmann V; Wiese M; Viazov S; Roggendorf M
Virus Res; 2009 Jun; 142(1-2):1-9. PubMed ID: 19103237
[TBL] [Abstract][Full Text] [Related]
22. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus infection: in vivo and in vitro models.
Brass V; Moradpour D; Blum HE
J Viral Hepat; 2007 Nov; 14 Suppl 1():64-7. PubMed ID: 17958645
[TBL] [Abstract][Full Text] [Related]
24. [Hepatitis C virus].
Querenghi F; Zoulim F
Rev Prat; 2000 May; 50(10):1060-5. PubMed ID: 10905089
[TBL] [Abstract][Full Text] [Related]
25. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
Régeard M; Lepère C; Trotard M; Gripon P; Le Seyec J
FEBS J; 2007 Sep; 274(18):4705-18. PubMed ID: 17824957
[TBL] [Abstract][Full Text] [Related]
26. Virology. Culture systems for hepatitis C virus in sight at last.
Cohen J
Science; 2005 Jun; 308(5728):1539-41. PubMed ID: 15947152
[No Abstract] [Full Text] [Related]
27. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
[TBL] [Abstract][Full Text] [Related]
28. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.
Yanagi M; St Claire M; Shapiro M; Emerson SU; Purcell RH; Bukh J
Virology; 1998 Apr; 244(1):161-72. PubMed ID: 9581788
[TBL] [Abstract][Full Text] [Related]
29. Adaptation of the hepatitis C virus to cell culture.
Kaul A; Wörz I; Bartenschlager R
Methods Mol Biol; 2009; 510():361-72. PubMed ID: 19009275
[TBL] [Abstract][Full Text] [Related]
30. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.
Kato N; Mori K; Abe K; Dansako H; Kuroki M; Ariumi Y; Wakita T; Ikeda M
Virus Res; 2009 Dec; 146(1-2):41-50. PubMed ID: 19720094
[TBL] [Abstract][Full Text] [Related]
31. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.
Meunier JC; Engle RE; Faulk K; Zhao M; Bartosch B; Alter H; Emerson SU; Cosset FL; Purcell RH; Bukh J
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4560-5. PubMed ID: 15767578
[TBL] [Abstract][Full Text] [Related]
32. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.
Tao W; Xu C; Ding Q; Li R; Xiang Y; Chung J; Zhong J
Virology; 2009 Dec; 395(1):67-76. PubMed ID: 19793603
[TBL] [Abstract][Full Text] [Related]
33. Host factors involved in the replication of hepatitis C virus.
Moriishi K; Matsuura Y
Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
[TBL] [Abstract][Full Text] [Related]
34. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences.
Sakai A; Claire MS; Faulk K; Govindarajan S; Emerson SU; Purcell RH; Bukh J
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11646-51. PubMed ID: 14504405
[TBL] [Abstract][Full Text] [Related]
35. A novel strategy to develop a robust infectious hepatitis C virus cell culture system directly from a clinical isolate.
Lu J; Xiang Y; Tao W; Li Q; Wang N; Gao Y; Xiang X; Xie Q; Zhong J
J Virol; 2014 Feb; 88(3):1484-91. PubMed ID: 24227861
[TBL] [Abstract][Full Text] [Related]
36. [Molecular epidemiology of chronic hepatitis C (HCV) virus].
Nitkiewicz J
Przegl Epidemiol; 2004; 58(3):413-21. PubMed ID: 15730005
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus entry: an intriguing challenge for drug discovery.
Meanwell NA
Curr Opin Investig Drugs; 2006 Aug; 7(8):727-32. PubMed ID: 16955684
[TBL] [Abstract][Full Text] [Related]
38. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
Li YP; Ramirez S; Mikkelsen L; Bukh J
J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880
[TBL] [Abstract][Full Text] [Related]
39. Generation of a recombinant reporter hepatitis C virus useful for the analyses of virus entry, intra-cellular replication and virion production.
Kamada K; Shoji I; Deng L; Aoki C; Ratnoglik SL; Wakita T; Hotta H
Microbes Infect; 2012 Jan; 14(1):69-78. PubMed ID: 21917232
[TBL] [Abstract][Full Text] [Related]
40. A recombinant replication-competent hepatitis C virus expressing Azami-Green, a bright green-emitting fluorescent protein, suitable for visualization of infected cells.
Hou W; Aoki C; Yu L; Wen X; Xue Y; Gao B; Liu W; Gao GF; Iwamoto A; Kitamura Y
Biochem Biophys Res Commun; 2008 Dec; 377(1):7-11. PubMed ID: 18786508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
